Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
198.20
-0.28 (-0.14%)
Nov 7, 2025, 2:46 PM EST - Market open
Natera Employees
Natera had 4,434 employees as of December 31, 2024. The number of employees increased by 1,141 or 34.65% compared to the previous year.
Employees
4,434
Change (1Y)
1,141
Growth (1Y)
34.65%
Revenue / Employee
$477,374
Profits / Employee
-$69,731
Market Cap
27.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
| Dec 31, 2023 | 3,293 | 275 | 9.11% |
| Dec 31, 2022 | 3,018 | 348 | 13.03% |
| Dec 31, 2021 | 2,670 | 855 | 47.11% |
| Dec 31, 2020 | 1,815 | 776 | 74.69% |
| Dec 31, 2019 | 1,039 | 64 | 6.56% |
| Dec 31, 2018 | 975 | 82 | 9.18% |
| Dec 31, 2017 | 893 | 41 | 4.81% |
| Dec 31, 2016 | 852 | 136 | 18.99% |
| Dec 31, 2015 | 716 | 42 | 6.23% |
| Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NTRA News
- 18 hours ago - Natera, Inc. (NTRA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 hours ago - Natera Reports Third Quarter 2025 Financial Results - Business Wire
- 7 days ago - Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT - Business Wire
- 8 days ago - Natera to Report its Third Quarter Results on November 6, 2025 - Business Wire
- 10 days ago - Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity - Business Wire
- 11 days ago - Halper Sadeh LLC Encourages Natera Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 14 days ago - Natera, Inc. (NTRA) Discusses Findings from ESMO Congress Transcript - Seeking Alpha
- 18 days ago - Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients - Business Wire